White House

The Readout Damian Garde

STAT Plus: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

D.C. Diagnosis Sarah Owermohle

STAT Plus: White House pharmacy under the microscope

Politics John Wilkerson

STAT Plus: Pharma’s attack on Medicare drug price negotiation might benefit Biden

Politics Brittany Trang

STAT Plus: The White House has a pharmacy — and it was a mess, a new investigation found

Health Care Inc. Bob Herman

Medicare Advantage update pushes Wall Street to reset expectations

Politics John Wilkerson

STAT Plus: FDA sets aggressive deadline for inspection overhaul

Exclusive Rachel Cohrs

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

Insurance Brittany Trang

STAT Plus: Biden changes will force health insurers to speed up and get more specific if they want to deny care

Politics John Wilkerson

STAT Plus: Copay coupons for some drugs must count toward deductibles, after Biden court move

D.C. Diagnosis Sarah Owermohle

STAT Plus: Health care negotiations on Capitol Hill are clear as mud

Politics Sarah Owermohle

STAT Plus: The new NIH director is walking a tightrope on Biden’s drug pricing vision

Business Brittany Trang

STAT Plus: Could private equity be the future of private practice? A new lobbying group thinks so

Politics Rachel Cohrs

STAT Plus: Courts will decide the future of Medicare’s power to negotiate drug prices within months

D.C. Diagnosis Sarah Owermohle

Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one

Special Report Sarah Owermohle

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

Politics Brittany Trang

STAT Plus: HHS names inaugural chief competition officer

Politics John Wilkerson

Biden’s FDA is letting Ron DeSantis import cheaper drugs from Canada. Who gets to take credit?

D.C. Diagnosis Sarah Owermohle

At JPM, how much health policy talk should we expect?

D.C. Diagnosis Rachel Cohrs

STAT Plus: An ugly fight over care for the poor in Texas

Politics Rachel Cohrs

STAT Plus: Pharmacies fear New Year’s financial squeeze from Biden administration rule

Politics John Wilkerson

STAT Plus: 3 FDA staffers to watch in 2024

Politics John Wilkerson

STAT Plus: Venture capital is still pouring into drug research despite Medicare price negotiation

Health Shravya Pant — Medill News Service

Pregnant cancer patients often have to terminate. Abortion pill restrictions could make that choice even harder

Hospitals Brittany Trang

STAT Plus: What the new health counsels at FTC, DOJ, and HHS might do

First Opinion Joseph P. Allen

STAT Plus: The Biden administration’s plan to use march-in rights to address drug prices would kill future world-changing innovations

Politics Sarah Owermohle

STAT Plus: Supreme Court will decide abortion pill access

Politics Rachel Cohrs

STAT Plus: UnitedHealth executive to head health insurance group AHIP

Insurance Tara Bannow

Sen. Warren pushes for more data on Medicare Advantage coverage hurdles, denials

Pharmalot Ed Silverman

STAT Plus: Biden proposal targeting pharma patents spurs industry fears and consumer doubts